IceCure Applauds ASBrS for Including Cryoablation in Breast Cancer Guidelines IceCure celebrates the American Society of Breast Surgeons' new guidelines, endorsing cryoablation for low-risk breast cancer patients. This marks a significant advancement in breast cancer treatment options.

IceCure Applauds ASBrS for Including Cryoablation in Breast Cancer Guidelines #Israel #Caesarea #Cryoablation #IceCure #ASBrS

IceCure's ProSense® Cryoablation Receives FDA Approval: Changing Breast Cancer Treatment for Older Women IceCure's ProSense® cryoablation system has received FDA marketing authorization for treating low-risk breast cancer in women aged 70 and above, marking a significant advancement in cancer care.

IceCure's ProSense® Cryoablation Receives FDA Approval: Changing Breast Cancer Treatment for Older Women #United_States #Caesarea #Breast_Cancer #ProSense® #IceCure

IceCure's ProSense® Showcases Promising Advances in Breast Cancer Care at EUSOBI 2025 IceCure Medical's ProSense® technology highlighted the potential of cryoablation as a minimally invasive treatment for early-stage breast cancer at EUSOBI 2025.

IceCure's ProSense® Showcases Promising Advances in Breast Cancer Care at EUSOBI 2025 #United_Kingdom #Cryoablation #ProSense #Aberdeen #IceCure

IceCure Medical Showcases Promising Cryoablation Results at CIRSE 2025 Annual Meeting IceCure Medical's ProSense® technology received positive feedback at the CIRSE 2025 Annual Meeting, showcasing innovative cryoablation studies and hands-on training sessions.

IceCure Medical Showcases Promising Cryoablation Results at CIRSE 2025 Annual Meeting #Israel #Barcelona #Cryoablation #ProSense #IceCure

IceCure's Revolutionary Cryoprobes Receive U.S. Patent Approval, Enhancing Patient Safety and Outcomes IceCure Medical has achieved U.S. patent approval for its innovative XSense™ cryoprobes, designed to improve patient safety and enhance cryoablation procedures.

IceCure's Revolutionary Cryoprobes Receive U.S. Patent Approval, Enhancing Patient Safety and Outcomes #Israel #Caesarea #ProSense #IceCure #XSense

ProSense® Shines at ECIO 2025: Innovative Cryoablation for Breast Cancer Treatment IceCure Medical's ProSense® featured prominently at ECIO 2025, highlighting its efficacy in breast cancer cryoablation. Experts praised its promising results.

ProSense® Shines at ECIO 2025: Innovative Cryoablation for Breast Cancer Treatment #Netherlands #Cryoablation #Rotterdam #ProSense® #IceCure